2021年6月2日全球新冠肺炎疫情及疫苗接种简报:日新增42.8万,科兴新冠疫苗列入世卫紧急使用清单

2021-06-02 MedSci整理 MedSci整理

截至北京时间2021年6月2日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过17189万例,新增428,482例,达到171,895,056

截至北京时间2021年6月2日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎COVID-19)病例超过17189万例,新增428,482例,达到171,895,056例。累计死亡病例357.5万例,达到3,575,075例,新增死亡为9,932例。康复为154,585,910例,重症和危重症病人达到90,668例;全球新冠确诊病例超过100万例的国家达28个,93个国家病例超10万例。昨日报道:2021年6月1日全球新冠肺炎疫情及疫苗接种简报:日新增35.0万,全球疫苗接种19亿剂次

科兴新冠疫苗列入世卫紧急使用清单,全球供应已超6亿剂

当地时间6月1日,世卫组织(WHO)宣布,北京科兴中维生物技术有限公司研制的新冠灭活疫苗通过了评审,正式列入“紧急使用清单”(EUL)。

WHO紧急使用清单程序是指为应对突发公共卫生事件,将新产品或未通过预认证的产品纳入采购范围的技术审评程序。全球新冠疫情暴发后,WHO修订了紧急使用程序指南,通过EUL评审成为各国为“新冠肺炎疫苗实施计划”(COVAX)提供疫苗的先决条件。

科兴于2020年10月10日正式向WHO提交纳入紧急使用清单申请,并按照WHO的要求先后提交了临床研究资料、非临床研究资料、质量和药学研究资料等,供其对疫苗安全性、有效性和产品质量进行持续评价。

2021年4月29日,WHO免疫战略咨询专家组对科兴新冠疫苗进行了系统审查,并对其在人群中的使用得出结论:整体上,使用科兴新冠疫苗的收益大于已知风险,推荐使用。

欧盟药品管理局也已于近日启动了对科兴新冠疫苗的滚动审查程序,这是科兴新冠疫苗在获得欧盟批准使用过程中迈出的第一步。

今年4月1日,科兴新冠疫苗原液车间(三期)建成投产,投产后的新冠疫苗年产能超20亿剂,有助于缓解全球新冠疫苗供应短缺的问题。

秘鲁修正新冠病例统计数据后,人均死亡率全球最高

秘鲁政府在咨询卫生专家团的意见后,发现有大量未被纳入统计的新冠死亡病例数据。经调整后,秘鲁现在是世界上人均新冠死亡率最高的国家,每100万居民中就有5484人死于新冠。

据悉,秘鲁总人口约3300万,据此前的数据显示,秘鲁每100万居民有2103人因感染新冠去世,位居第13位。

高福院士:新冠疫苗研发全球现有7条路线88个进入临床试验

不同的新冠肺炎疫情防控策略都表明,疫苗可能是最终的解决方案。目前,全球共有7条疫苗研发技术路线,分别是灭活苗、减毒活疫苗、重组蛋白疫苗、病毒载体疫苗、病毒样颗粒疫苗以及核酸疫苗(包括DNA疫苗和RNA疫苗)。现在全球共有272个候选疫苗,其中88个进入临床试验。

在全球新冠疫苗研发中,中国目前已有3款灭活疫苗、1款腺病毒载体疫苗获附条件上市,1款重组蛋白疫苗获批应急使用。这几款疫苗均表现出良好的免疫原性和安全性。

北京市新冠疫苗接种超1700万人!

截至6月1日18时,北京市累计接种新冠疫苗人数达到1715万人,其中朝阳区累计接种超过300万人,海淀区累计接种超过280万人,西城区、丰台区、通州区、顺义区、昌平区、大兴区累计接种超过100万人。60岁及以上人群累计接种241万人,90岁及以上人群接种4320人。累计为28640名外籍人士和8231名港澳台同胞接种了新冠疫苗。

全市累计接种新冠疫苗剂次达到3141万剂,其中朝阳区、海淀区累计接种超过500万剂。18岁及以上人群“第1剂”新冠疫苗接种率达到88.1%,全程接种率达到73.6%。北京市16区及经开区18岁及以上人群“第1剂”新冠疫苗接种率已全部突破80%,其中东城区、石景山区、房山区、通州区、顺义区、昌平区、大兴区7个区18周岁及以上人群接种率超过90%。


新华社资料图

2021年5月31日:31省份已累计报告接种新冠病毒疫苗66146.8万剂次,新增2229.6万剂次,再创新高

据国家卫健委网站消息,截至2021年5月31日,31个省(自治区、直辖市)和新疆生产建设兵团累计报告接种新冠病毒疫苗66146.8万剂次。

昨日累计报告接种新冠病毒疫苗63917.2万剂次,单日接种新冠病毒疫苗2229.6万剂次。

中国每日疫苗接种趋势

全球疫苗接种速度,以每百人口为计,蒙古速度最快,中国第二

美国新增新冠病例已降到6000例以下,再创新低!

据美国约翰霍普斯金大学6月1日的数据显示,截至美国东部时间5月31日23点59分,在过去24小时内,美国新增新冠肺炎确诊病例5725例,较前一日又减少了990例,创去年3月19日以来新低;新增相关死亡138例,较前一日增加了14例,创去年3月8日以来新低。

据美国疾病控制和预防中心(CDC)的最新数据显示,全美目前有168489729人接种了一剂新冠疫苗,135867425人接种了两剂。

截至目前,美国累计确诊病例至少已有33284140例,至少有595181人因新冠肺炎死亡。

全球新冠疫苗接种19.4亿剂次

Country
Cumulative COVID-19 vaccinations doses
World 1.94 billion
Asia 1.06 billion
Upper middle income 909.89 million
High income 738.48 million
China 661.47 million
North America 360.95 million
Europe 356.72 million
United States May 30, 2021 294.93 million
Lower middle income 283.08 million
European Union 246.96 million
India 210.45 million
South America 119.64 million
Brazil 67.48 million
United Kingdom May 30, 2021 64.92 million
England May 30, 2021 54.66 million
Germany May 30, 2021 49.94 million
France May 30, 2021 36.22 million
Italy 34.95 million
Africa 32.81 million
Mexico 30.48 million
Turkey 29.17 million
Russia 28.50 million
Indonesia 27.05 million
Spain May 30, 2021 26.83 million
Canada 23.86 million
Poland 20.08 million
Chile May 30, 2021 18.47 million
Saudi Arabia 14.21 million
Morocco 14.14 million
Japan 13.21 million
United Arab Emirates 12.87 million
Argentina 12.26 million
Israel 10.58 million

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1008647, encodeId=a065100864e15, content=长知识了, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210602/711e1c5a66aa4613b631b770d1f90d30/93509d3f68cd41059530011f86166a3b.jpg, createdBy=c0aa5511547, createdName=131****6918, createdTime=Tue Aug 17 11:29:32 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006543, encodeId=864b1006543e6, content=收益大于风险, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb4f5455945, createdName=ms3000000488901208, createdTime=Tue Aug 10 07:42:20 CST 2021, time=2021-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258011, encodeId=09fd125801106, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Thu Jun 03 23:00:29 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1523351, encodeId=942e1523351c4, content=<a href='/topic/show?id=1a1de7006b0' target=_blank style='color:#2F92EE;'>#紧急#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77006, encryptionId=1a1de7006b0, topicName=紧急)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b88211514540, createdName=guguangxiang, createdTime=Thu Jun 03 23:00:29 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970298, encodeId=82f29e029877, content=谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210602/7237fe7c296a4b53ba8ff5f08c7d4ced/ea19f8cc957349d18c24b3d791a8af0e.jpg, createdBy=796e5511505, createdName=诚信使者, createdTime=Wed Jun 02 11:53:34 CST 2021, time=2021-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029553, encodeId=9df5102955370, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Wed Jun 02 11:00:29 CST 2021, time=2021-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970233, encodeId=f6639e023367, content=有的期刊涨得好快哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=48875142674, createdName=贵医陈超, createdTime=Wed Jun 02 08:01:15 CST 2021, time=2021-06-02, status=1, ipAttribution=)]
    2021-08-17 131****6918

    长知识了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1008647, encodeId=a065100864e15, content=长知识了, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210602/711e1c5a66aa4613b631b770d1f90d30/93509d3f68cd41059530011f86166a3b.jpg, createdBy=c0aa5511547, createdName=131****6918, createdTime=Tue Aug 17 11:29:32 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006543, encodeId=864b1006543e6, content=收益大于风险, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb4f5455945, createdName=ms3000000488901208, createdTime=Tue Aug 10 07:42:20 CST 2021, time=2021-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258011, encodeId=09fd125801106, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Thu Jun 03 23:00:29 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1523351, encodeId=942e1523351c4, content=<a href='/topic/show?id=1a1de7006b0' target=_blank style='color:#2F92EE;'>#紧急#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77006, encryptionId=1a1de7006b0, topicName=紧急)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b88211514540, createdName=guguangxiang, createdTime=Thu Jun 03 23:00:29 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970298, encodeId=82f29e029877, content=谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210602/7237fe7c296a4b53ba8ff5f08c7d4ced/ea19f8cc957349d18c24b3d791a8af0e.jpg, createdBy=796e5511505, createdName=诚信使者, createdTime=Wed Jun 02 11:53:34 CST 2021, time=2021-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029553, encodeId=9df5102955370, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Wed Jun 02 11:00:29 CST 2021, time=2021-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970233, encodeId=f6639e023367, content=有的期刊涨得好快哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=48875142674, createdName=贵医陈超, createdTime=Wed Jun 02 08:01:15 CST 2021, time=2021-06-02, status=1, ipAttribution=)]
    2021-08-10 ms3000000488901208

    收益大于风险

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1008647, encodeId=a065100864e15, content=长知识了, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210602/711e1c5a66aa4613b631b770d1f90d30/93509d3f68cd41059530011f86166a3b.jpg, createdBy=c0aa5511547, createdName=131****6918, createdTime=Tue Aug 17 11:29:32 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006543, encodeId=864b1006543e6, content=收益大于风险, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb4f5455945, createdName=ms3000000488901208, createdTime=Tue Aug 10 07:42:20 CST 2021, time=2021-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258011, encodeId=09fd125801106, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Thu Jun 03 23:00:29 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1523351, encodeId=942e1523351c4, content=<a href='/topic/show?id=1a1de7006b0' target=_blank style='color:#2F92EE;'>#紧急#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77006, encryptionId=1a1de7006b0, topicName=紧急)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b88211514540, createdName=guguangxiang, createdTime=Thu Jun 03 23:00:29 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970298, encodeId=82f29e029877, content=谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210602/7237fe7c296a4b53ba8ff5f08c7d4ced/ea19f8cc957349d18c24b3d791a8af0e.jpg, createdBy=796e5511505, createdName=诚信使者, createdTime=Wed Jun 02 11:53:34 CST 2021, time=2021-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029553, encodeId=9df5102955370, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Wed Jun 02 11:00:29 CST 2021, time=2021-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970233, encodeId=f6639e023367, content=有的期刊涨得好快哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=48875142674, createdName=贵医陈超, createdTime=Wed Jun 02 08:01:15 CST 2021, time=2021-06-02, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1008647, encodeId=a065100864e15, content=长知识了, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210602/711e1c5a66aa4613b631b770d1f90d30/93509d3f68cd41059530011f86166a3b.jpg, createdBy=c0aa5511547, createdName=131****6918, createdTime=Tue Aug 17 11:29:32 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006543, encodeId=864b1006543e6, content=收益大于风险, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb4f5455945, createdName=ms3000000488901208, createdTime=Tue Aug 10 07:42:20 CST 2021, time=2021-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258011, encodeId=09fd125801106, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Thu Jun 03 23:00:29 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1523351, encodeId=942e1523351c4, content=<a href='/topic/show?id=1a1de7006b0' target=_blank style='color:#2F92EE;'>#紧急#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77006, encryptionId=1a1de7006b0, topicName=紧急)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b88211514540, createdName=guguangxiang, createdTime=Thu Jun 03 23:00:29 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970298, encodeId=82f29e029877, content=谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210602/7237fe7c296a4b53ba8ff5f08c7d4ced/ea19f8cc957349d18c24b3d791a8af0e.jpg, createdBy=796e5511505, createdName=诚信使者, createdTime=Wed Jun 02 11:53:34 CST 2021, time=2021-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029553, encodeId=9df5102955370, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Wed Jun 02 11:00:29 CST 2021, time=2021-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970233, encodeId=f6639e023367, content=有的期刊涨得好快哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=48875142674, createdName=贵医陈超, createdTime=Wed Jun 02 08:01:15 CST 2021, time=2021-06-02, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1008647, encodeId=a065100864e15, content=长知识了, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210602/711e1c5a66aa4613b631b770d1f90d30/93509d3f68cd41059530011f86166a3b.jpg, createdBy=c0aa5511547, createdName=131****6918, createdTime=Tue Aug 17 11:29:32 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006543, encodeId=864b1006543e6, content=收益大于风险, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb4f5455945, createdName=ms3000000488901208, createdTime=Tue Aug 10 07:42:20 CST 2021, time=2021-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258011, encodeId=09fd125801106, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Thu Jun 03 23:00:29 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1523351, encodeId=942e1523351c4, content=<a href='/topic/show?id=1a1de7006b0' target=_blank style='color:#2F92EE;'>#紧急#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77006, encryptionId=1a1de7006b0, topicName=紧急)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b88211514540, createdName=guguangxiang, createdTime=Thu Jun 03 23:00:29 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970298, encodeId=82f29e029877, content=谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210602/7237fe7c296a4b53ba8ff5f08c7d4ced/ea19f8cc957349d18c24b3d791a8af0e.jpg, createdBy=796e5511505, createdName=诚信使者, createdTime=Wed Jun 02 11:53:34 CST 2021, time=2021-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029553, encodeId=9df5102955370, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Wed Jun 02 11:00:29 CST 2021, time=2021-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970233, encodeId=f6639e023367, content=有的期刊涨得好快哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=48875142674, createdName=贵医陈超, createdTime=Wed Jun 02 08:01:15 CST 2021, time=2021-06-02, status=1, ipAttribution=)]
    2021-06-02 诚信使者

    谢谢

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1008647, encodeId=a065100864e15, content=长知识了, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210602/711e1c5a66aa4613b631b770d1f90d30/93509d3f68cd41059530011f86166a3b.jpg, createdBy=c0aa5511547, createdName=131****6918, createdTime=Tue Aug 17 11:29:32 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006543, encodeId=864b1006543e6, content=收益大于风险, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb4f5455945, createdName=ms3000000488901208, createdTime=Tue Aug 10 07:42:20 CST 2021, time=2021-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258011, encodeId=09fd125801106, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Thu Jun 03 23:00:29 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1523351, encodeId=942e1523351c4, content=<a href='/topic/show?id=1a1de7006b0' target=_blank style='color:#2F92EE;'>#紧急#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77006, encryptionId=1a1de7006b0, topicName=紧急)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b88211514540, createdName=guguangxiang, createdTime=Thu Jun 03 23:00:29 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970298, encodeId=82f29e029877, content=谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210602/7237fe7c296a4b53ba8ff5f08c7d4ced/ea19f8cc957349d18c24b3d791a8af0e.jpg, createdBy=796e5511505, createdName=诚信使者, createdTime=Wed Jun 02 11:53:34 CST 2021, time=2021-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029553, encodeId=9df5102955370, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Wed Jun 02 11:00:29 CST 2021, time=2021-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970233, encodeId=f6639e023367, content=有的期刊涨得好快哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=48875142674, createdName=贵医陈超, createdTime=Wed Jun 02 08:01:15 CST 2021, time=2021-06-02, status=1, ipAttribution=)]
    2021-06-02 公卫新人

    新冠肺炎,疫情何时才能消失

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1008647, encodeId=a065100864e15, content=长知识了, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210602/711e1c5a66aa4613b631b770d1f90d30/93509d3f68cd41059530011f86166a3b.jpg, createdBy=c0aa5511547, createdName=131****6918, createdTime=Tue Aug 17 11:29:32 CST 2021, time=2021-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006543, encodeId=864b1006543e6, content=收益大于风险, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=eb4f5455945, createdName=ms3000000488901208, createdTime=Tue Aug 10 07:42:20 CST 2021, time=2021-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258011, encodeId=09fd125801106, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Thu Jun 03 23:00:29 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1523351, encodeId=942e1523351c4, content=<a href='/topic/show?id=1a1de7006b0' target=_blank style='color:#2F92EE;'>#紧急#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77006, encryptionId=1a1de7006b0, topicName=紧急)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b88211514540, createdName=guguangxiang, createdTime=Thu Jun 03 23:00:29 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970298, encodeId=82f29e029877, content=谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210602/7237fe7c296a4b53ba8ff5f08c7d4ced/ea19f8cc957349d18c24b3d791a8af0e.jpg, createdBy=796e5511505, createdName=诚信使者, createdTime=Wed Jun 02 11:53:34 CST 2021, time=2021-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1029553, encodeId=9df5102955370, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Wed Jun 02 11:00:29 CST 2021, time=2021-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970233, encodeId=f6639e023367, content=有的期刊涨得好快哦, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=48875142674, createdName=贵医陈超, createdTime=Wed Jun 02 08:01:15 CST 2021, time=2021-06-02, status=1, ipAttribution=)]
    2021-06-02 贵医陈超

    有的期刊涨得好快哦

    0

相关资讯

2021年5月31日全球新冠肺炎疫情及疫苗接种简报:日新增38.6万,全球新冠疫苗产能达100亿剂次

截至北京时间2021年5月31日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过17100万例,新增385,896例,达到171,004,02

2021年5月29日全球新冠肺炎(COVID-19)疫情简报,日新增48.6万,欧盟向日本出口超1亿剂新冠疫苗

Worldometers世界实时统计数据显示,截至北京时间2021年5月29日7时01分,全球累计确诊新冠肺炎(COVID-19)病例超过17010万例,新增485,551例,达到170,102,52

2021年5月30日全球新冠肺炎(COVID-19)疫情简报,日新增48.1万,新冠疫苗保护期可达1年

Worldometers世界实时统计数据显示,截至北京时间2021年5月30日7时01分,全球累计确诊新冠肺炎(COVID-19)病例超过17060万例,新增480,967例,达到170,607,04

中疾控首次发布我国新冠疫苗接种不良反应监测情况,报告发生率为11.86/10万剂次

接种新冠病毒疫苗2.65亿剂次,报告预防接种不良反应31434例,报告发生率为11.86/10万剂次。

中疾控:已经已经在针对变异株研制新一代疫苗,现有疫苗依然有效!

据央视新闻消息,中国疾控中心研究员邵一鸣:已经在针对变异株研制新一代疫苗,我们国家灭活疫苗的技术路线特别适合快速应对变异株。整个疫苗工艺不做丝毫改变,只是在投料端把原来的早期流行株换成现在对我们有威胁